TNSN06420A1 - Methods of treatment of endobronchial infections - Google Patents

Methods of treatment of endobronchial infections

Info

Publication number
TNSN06420A1
TNSN06420A1 TNP2006000420A TNSN06420A TNSN06420A1 TN SN06420 A1 TNSN06420 A1 TN SN06420A1 TN P2006000420 A TNP2006000420 A TN P2006000420A TN SN06420 A TNSN06420 A TN SN06420A TN SN06420 A1 TNSN06420 A1 TN SN06420A1
Authority
TN
Tunisia
Prior art keywords
treatment
methods
endobronchial
endobronchial infections
patient
Prior art date
Application number
TNP2006000420A
Other languages
English (en)
French (fr)
Inventor
Carlos Rodriguez
Thomas E Tarara
John D Lord
Peter Challoner
Original Assignee
Novartis Ag
Novartis Vaccines & Diagnostics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis Ag, Novartis Vaccines & Diagnostics Inc filed Critical Novartis Ag
Publication of TNSN06420A1 publication Critical patent/TNSN06420A1/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/10Dispersions; Emulsions
    • A61K9/12Aerosols; Foams
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/007Pulmonary tract; Aromatherapy
    • A61K9/0073Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/0075Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carrier particles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/02Local antiseptics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Pulmonology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Molecular Biology (AREA)
  • Otolaryngology (AREA)
  • Dispersion Chemistry (AREA)
  • Diabetes (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
TNP2006000420A 2004-06-18 2006-12-18 Methods of treatment of endobronchial infections TNSN06420A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US58084804P 2004-06-18 2004-06-18
PCT/US2005/021952 WO2006002178A1 (en) 2004-06-18 2005-06-20 Methods of treatment of endobronchial infections

Publications (1)

Publication Number Publication Date
TNSN06420A1 true TNSN06420A1 (en) 2008-02-22

Family

ID=35782127

Family Applications (1)

Application Number Title Priority Date Filing Date
TNP2006000420A TNSN06420A1 (en) 2004-06-18 2006-12-18 Methods of treatment of endobronchial infections

Country Status (25)

Country Link
US (3) US20080214481A1 (enExample)
EP (1) EP1765288B1 (enExample)
JP (3) JP2008503500A (enExample)
KR (2) KR20070026604A (enExample)
CN (1) CN101014320B (enExample)
AU (1) AU2005258078B2 (enExample)
BR (1) BRPI0512146A (enExample)
CA (1) CA2570976C (enExample)
DK (1) DK1765288T3 (enExample)
EC (1) ECSP077182A (enExample)
ES (1) ES2399279T3 (enExample)
HR (1) HRP20130076T1 (enExample)
IL (1) IL179873A (enExample)
MA (1) MA28740B1 (enExample)
MX (1) MXPA06014567A (enExample)
NO (1) NO338799B1 (enExample)
NZ (1) NZ552047A (enExample)
PL (1) PL1765288T3 (enExample)
PT (1) PT1765288E (enExample)
RU (1) RU2389477C2 (enExample)
SG (1) SG153833A1 (enExample)
SI (1) SI1765288T1 (enExample)
TN (1) TNSN06420A1 (enExample)
WO (1) WO2006002178A1 (enExample)
ZA (1) ZA200700420B (enExample)

Families Citing this family (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003053411A1 (en) 2001-12-19 2003-07-03 Nektar Therapeutics Pulmonary delivery of aminoglycosides
US7381184B2 (en) 2002-11-05 2008-06-03 Abbott Diabetes Care Inc. Sensor inserter assembly
USD902408S1 (en) 2003-11-05 2020-11-17 Abbott Diabetes Care Inc. Analyte sensor control unit
US10226207B2 (en) 2004-12-29 2019-03-12 Abbott Diabetes Care Inc. Sensor inserter having introducer
US7883464B2 (en) 2005-09-30 2011-02-08 Abbott Diabetes Care Inc. Integrated transmitter unit and sensor introducer mechanism and methods of use
US9259175B2 (en) 2006-10-23 2016-02-16 Abbott Diabetes Care, Inc. Flexible patch for fluid delivery and monitoring body analytes
US9788771B2 (en) 2006-10-23 2017-10-17 Abbott Diabetes Care Inc. Variable speed sensor insertion devices and methods of use
US8512243B2 (en) 2005-09-30 2013-08-20 Abbott Diabetes Care Inc. Integrated introducer and transmitter assembly and methods of use
US7697967B2 (en) 2005-12-28 2010-04-13 Abbott Diabetes Care Inc. Method and apparatus for providing analyte sensor insertion
US9398882B2 (en) 2005-09-30 2016-07-26 Abbott Diabetes Care Inc. Method and apparatus for providing analyte sensor and data processing device
US8029441B2 (en) 2006-02-28 2011-10-04 Abbott Diabetes Care Inc. Analyte sensor transmitter unit configuration for a data monitoring and management system
US8333714B2 (en) 2006-09-10 2012-12-18 Abbott Diabetes Care Inc. Method and system for providing an integrated analyte sensor insertion device and data processing unit
US9521968B2 (en) 2005-09-30 2016-12-20 Abbott Diabetes Care Inc. Analyte sensor retention mechanism and methods of use
US11298058B2 (en) 2005-12-28 2022-04-12 Abbott Diabetes Care Inc. Method and apparatus for providing analyte sensor insertion
CA2665764C (en) 2006-10-11 2015-05-26 Laboratoires Smb S.A. Pharmaceutical anti-infective composition for inhalation
EP1938822A1 (en) * 2006-12-21 2008-07-02 Novartis AG Combination therapy for the treatment of airways disease
KR101621986B1 (ko) * 2008-05-15 2016-05-17 노파르티스 아게 플루오로퀴놀론의 폐 전달
US9402544B2 (en) 2009-02-03 2016-08-02 Abbott Diabetes Care Inc. Analyte sensor and apparatus for insertion of the sensor
TWI792140B (zh) * 2009-05-29 2023-02-11 美商沛爾醫療股份有限公司 用於經由呼吸道遞送二或更多種活性藥劑的組成物、方法與系統
US8815258B2 (en) 2009-05-29 2014-08-26 Pearl Therapeutics, Inc. Compositions, methods and systems for respiratory delivery of two or more active agents
CN102473276B (zh) 2009-08-31 2016-04-13 雅培糖尿病护理公司 医疗装置及方法
CA2784207C (en) * 2009-12-14 2018-06-05 Chiesi Farmaceutici S.P.A. Antibiotic microparticles for inhalation
BRPI1105778A2 (pt) 2010-03-24 2016-05-03 Abbott Diabetes Care Inc "insersores de dispositivo médico e processos de inserção e uso de dispositivos médicos"
US11064921B2 (en) 2010-06-29 2021-07-20 Abbott Diabetes Care Inc. Devices, systems and methods for on-skin or on-body mounting of medical devices
US9572774B2 (en) 2011-05-19 2017-02-21 Savara Inc. Dry powder vancomycin compositions and associated methods
US8826904B2 (en) 2011-07-12 2014-09-09 Cardeas Pharma Corporation Formulations of aminoglycoside and fosfomycin combinations and methods and systems for treatment of ventilator associated pneumonia (VAP) and ventilator associated tracheal (VAT) bronchitis
BR112014000275A2 (pt) 2011-07-12 2017-04-18 Cardeas Pharma Inc formulações aperfeiçoadas de combinações de aminoglicosídeo e fosfomicina e métodos e sistemas para o tratamento de pneumonia associada à ventilação mecânica (pavm) e traqueobronquite associada à ventilação mecânica (vat)
WO2013090215A2 (en) 2011-12-11 2013-06-20 Abbot Diabetes Care Inc. Analyte sensor devices, connections, and methods
WO2014055456A1 (en) * 2012-10-07 2014-04-10 Abbott Diabetes Care Inc. Medical device insertion indicators
CN102949379B (zh) * 2012-11-14 2014-11-05 中山大学 硫酸奈替米星吸入粉雾剂及其制备方法
SG11201507286QA (en) 2013-03-15 2015-10-29 Pearl Therapeutics Inc Methods and systems for conditioning of particulate crystalline materials
US10674944B2 (en) 2015-05-14 2020-06-09 Abbott Diabetes Care Inc. Compact medical device inserters and related systems and methods
US10213139B2 (en) 2015-05-14 2019-02-26 Abbott Diabetes Care Inc. Systems, devices, and methods for assembling an applicator and sensor control device
CN110461217B (zh) 2017-01-23 2022-09-16 雅培糖尿病护理公司 用于分析物传感器插入的系统、装置和方法
WO2020163416A1 (en) * 2019-02-05 2020-08-13 Mylan Inc Devices and methods for tobramycin inhalation treatment
USD1002852S1 (en) 2019-06-06 2023-10-24 Abbott Diabetes Care Inc. Analyte sensor device
CA3188510A1 (en) 2020-08-31 2022-03-03 Vivek S. RAO Systems, devices, and methods for analyte sensor insertion
USD999913S1 (en) 2020-12-21 2023-09-26 Abbott Diabetes Care Inc Analyte sensor inserter

Family Cites Families (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5A (en) * 1836-08-10 Thomas Blanchard Machine for mortising solid wooden shells of ships' tackle-blocks
FR2224175B1 (enExample) 1973-04-04 1978-04-14 Isf Spa
US4069819A (en) 1973-04-13 1978-01-24 Societa Farmaceutici S.P.A. Inhalation device
IT1017153B (it) 1974-07-15 1977-07-20 Isf Spa Apparecchio per inalazioni
SE438261B (sv) 1981-07-08 1985-04-15 Draco Ab Anvendning i dosinhalator av ett perforerat membran
GB8314308D0 (en) 1983-05-24 1983-06-29 Matburn Holdings Ltd Medical administration devices
SU1335297A1 (ru) * 1984-06-15 1987-09-07 Донецкий медицинский институт им.М.Горького Способ лечени больных хроническими заболевани ми легких
US4805811A (en) 1985-03-29 1989-02-21 Aktiebolaget Draco Dosage device
SE448277B (sv) 1985-04-12 1987-02-09 Draco Ab Indikeringsanordning vid en doseringsanordning for lekemedel
IT1228459B (it) 1989-02-23 1991-06-19 Phidea S R L Inalatore con svuotamento regolare e completo della capsula.
GB8909891D0 (en) 1989-04-28 1989-06-14 Riker Laboratories Inc Device
IT1243344B (it) 1990-07-16 1994-06-10 Promo Pack Sa Inalatore plurimonodose per medicamenti in polvere
CA2112674C (en) 1991-07-02 2005-10-04 John S. Patton Method and device for delivering aerosolized medicaments
US5785049A (en) 1994-09-21 1998-07-28 Inhale Therapeutic Systems Method and apparatus for dispersion of dry powder medicaments
IS1736B (is) 1993-10-01 1999-12-30 Astra Ab Aðferð og tæki sem stuðla að aukinni samloðun agna
US5388572A (en) 1993-10-26 1995-02-14 Tenax Corporation (A Connecticut Corp.) Dry powder medicament inhalator having an inhalation-activated piston to aerosolize dose and deliver same
WO1995031479A1 (en) 1994-05-18 1995-11-23 Inhale Therapeutic Systems, Inc. Methods and compositions for the dry powder formulation of interferons
CZ289029B6 (cs) 1994-09-21 2001-10-17 Inhale Therapeutic Systems Způsob aerosolizace práąku, zejména práąkového léku a zařízení k provádění tohoto způsobu
US5522385A (en) 1994-09-27 1996-06-04 Aradigm Corporation Dynamic particle size control for aerosolized drug delivery
US5508269A (en) * 1994-10-19 1996-04-16 Pathogenesis Corporation Aminoglycoside formulation for aerosolization
ES2237767T3 (es) 1995-04-14 2005-08-01 Nektar Therapeutics Composiciones farmaceuticas en polvo que tienen una dispersabilidad mejorada.
US5826633A (en) 1996-04-26 1998-10-27 Inhale Therapeutic Systems Powder filling systems, apparatus and methods
WO1999061003A1 (en) * 1998-05-27 1999-12-02 Euroceltique S.A. Drug delivery system comprising a tightly compacted solid medicament stock
SI20959A (sl) * 1998-12-17 2003-02-28 Pathogenesis Corporation Metoda za zdravljenje hudega kroničnega bronhitisa (bronhiektazije) z aerosoliziranimi antibiotiki
US6586008B1 (en) 1999-08-25 2003-07-01 Advanced Inhalation Research, Inc. Use of simple amino acids to form porous particles during spray drying
CA2382821A1 (en) 1999-08-25 2001-03-01 Advanced Inhalation Research, Inc. Modulation of release from dry powder formulations
US7871598B1 (en) 2000-05-10 2011-01-18 Novartis Ag Stable metal ion-lipid powdered pharmaceutical compositions for drug delivery and methods of use
CA2382133C (en) 2000-05-10 2010-11-23 Alliance Pharmaceutical Corporation Phospholipid-based powders for drug delivery
US6613308B2 (en) 2000-09-19 2003-09-02 Advanced Inhalation Research, Inc. Pulmonary delivery in treating disorders of the central nervous system
PT1320355E (pt) 2001-05-18 2006-08-31 Chiron Corp Sistema para administracao de uma formulacao de tobramicina
DE10131917A1 (de) 2001-07-02 2003-01-23 Infineon Technologies Ag Verfahren zur Erzeugung einer stufenförmigen Struktur auf einem Substrat
ATE509651T1 (de) 2001-11-14 2011-06-15 Novartis Ag Aerosol-vernebler bestehend aus koppelbarem haupt-und endstück
US20030094173A1 (en) 2001-11-14 2003-05-22 Inhale Therapeutic Systems, Inc. Aerosolization device with improved endpiece connection
WO2003053411A1 (en) 2001-12-19 2003-07-03 Nektar Therapeutics Pulmonary delivery of aminoglycosides
JP4739672B2 (ja) 2001-12-21 2011-08-03 ネクター セラピューティクス 湿気のバリアを有するカプセルパッケージ
KR20050003416A (ko) 2002-05-07 2005-01-10 넥타르 테라퓨틱스 건조분말 흡입기용 캡슐 및 이의 제조 및 사용 방법
CN1493297A (zh) * 2003-09-13 2004-05-05 南昌弘益科技有限公司 妥布霉素吸入粉雾剂及其制备方法

Also Published As

Publication number Publication date
RU2389477C2 (ru) 2010-05-20
CN101014320B (zh) 2011-05-18
HRP20130076T1 (hr) 2013-03-31
BRPI0512146A (pt) 2008-02-12
MXPA06014567A (es) 2007-07-24
US20110097412A1 (en) 2011-04-28
NO338799B1 (no) 2016-10-24
IL179873A0 (en) 2007-05-15
ZA200700420B (en) 2008-05-28
AU2005258078A1 (en) 2006-01-05
MA28740B1 (fr) 2007-07-02
WO2006002178A1 (en) 2006-01-05
KR20070026604A (ko) 2007-03-08
KR20120131245A (ko) 2012-12-04
AU2005258078B2 (en) 2010-09-30
CA2570976A1 (en) 2006-01-05
PT1765288E (pt) 2013-01-29
IL179873A (en) 2014-09-30
JP2012107047A (ja) 2012-06-07
EP1765288A4 (en) 2009-05-13
JP2013056947A (ja) 2013-03-28
CA2570976C (en) 2013-08-13
DK1765288T3 (da) 2013-02-11
NZ552047A (en) 2009-11-27
US20120148641A1 (en) 2012-06-14
SG153833A1 (en) 2009-07-29
EP1765288B1 (en) 2012-11-07
JP2008503500A (ja) 2008-02-07
US8664187B2 (en) 2014-03-04
PL1765288T3 (pl) 2013-04-30
RU2007101906A (ru) 2008-07-27
ES2399279T3 (es) 2013-03-27
CN101014320A (zh) 2007-08-08
NO20070253L (no) 2007-03-13
SI1765288T1 (sl) 2013-02-28
EP1765288A1 (en) 2007-03-28
ECSP077182A (es) 2007-05-30
US20080214481A1 (en) 2008-09-04

Similar Documents

Publication Publication Date Title
SG153833A1 (en) Methods of treatment of endobronchial infections
UA96964C2 (ru) Соединения полициклической мочевины с антибактериальными свойствами
UA94901C2 (ru) Антибактериальные производные пиперидина
SI1278549T1 (sl) Sestavek, ki vsebuje ciklodekstrin in glikopeptidni antibiotik
WO2001092288A3 (en) Cobalamin compounds useful as antibiotic agents and as imaging agents
NO20083250L (no) Antibakterielle pyrrolopyridiner, pyrrolopyrimidiner og pyrroloazepiner
WO2008020227A3 (en) Antibacterial pyrrolecarboxamides
WO2008020229A3 (en) Antibacterial pyrrolecarboxamides
TW200734344A (en) Antibacterial agents
GEP20094834B (en) Macrolides, pharmaceutical compositions containing them and their use for treatment of bacterial infections
TW200626585A (en) 18-membered macrocycles and analogs thereof
MX2007010478A (es) Glicopeptidos semisinteticos con actividad antibiotica.
SG162614A1 (en) Bicyclic 6-alkylidene-penems as beta-lactamases inhibitors
MX2009006325A (es) Compuestos de heteroaril-heteroarilo como inhibidores de cdk para el tratamiento de cancer, inflamacion e infecciones virales.
MY148124A (en) Preparation of a crystalline antibiotic substance
WO2006120563A3 (en) Antibacterial agents
ECSP045405A (es) Penems 6-alquiliden heterotriciclil como inhibidores de la beta lactamasa
ECSP088132A (es) INHIBIDORES DE 6-ALQUILIDENO-PENEME B-LACTAMASA BICÍCLICOS Y COMBINACIÓN ANTIBIÓTICA DE ß-LACTAMA: UN ANTIBIÓTICO DE AMPLIO ESPECTRO
WO2006093933A3 (en) Semi-synthetic rearranged vancomycin/desmethyl-vancomycin-based glycopeptides with antibiotic activity
ATE311885T1 (de) Monobactam-antibakterielle verbindungen und anwendungsverfahren
CY1113562T1 (el) Σκευασματα τομπραμυκινης για τη θεραπεια ενδοβρογχικων λοιμωξεων
WO2006094143A3 (en) Non-systemic antibiotic formulations and related method of use and treatment of upper respiratory infections
MX2010014248A (es) Nuevos antibioticos de trinem e inhibidores de beta-lactamasas.
GT200600332A (es) Inhibidores de 6-alquiliden-penem beta-lactamasa triciclicos y combinación de antibióticos de b-lactama: un antibiotico de amplio espectro
WO2009077485A3 (en) 1(2)h-tetrazol-5-yl-phenyl-oxazolidinones as antibacterial agents